Back

Nuclear speckles regulate HIF-2α programs and correlate with patient survival in kidney cancer

Alexander, K. A.; Yu, R.; Skuli, N.; Coffey, N. J.; Nguyen, S.; Faunce, C.; Huang, H.; Dardani, I.; Good, A. L.; Lim, J.; Li, C.; Biddle, N.; Joyce, E. F.; Raj, A.; Lee, D.; Keith, B.; Simon, M. C.; Berger, S. L.

2023-09-16 cancer biology
10.1101/2023.09.14.557228 bioRxiv
Show abstract

Nuclear speckles are membrane-less bodies within the cell nucleus enriched in RNA biogenesis, processing, and export factors. In this study we investigated speckle phenotype variation in human cancer, finding a reproducible speckle signature, based on RNA expression of speckle-resident proteins, across >20 cancer types. Of these, clear cell renal cell carcinoma (ccRCC) exhibited a clear correlation between the presence of this speckle expression signature, imaging-based speckle phenotype, and clinical outcomes. ccRCC is typified by hyperactivation of the HIF-2 transcription factor, and we demonstrate here that HIF-2 drives physical association of a select subset of its target genes with nuclear speckles. Disruption of HIF-2-driven speckle association via deletion of its speckle targeting motifs (STMs)--defined in this study--led to defective induction of speckle-associating HIF-2 target genes without impacting non-speckle-associating HIF-2 target genes. We further identify the RNA export complex, TREX, as being specifically altered in speckle signature, and knockdown of key TREX component, ALYREF, also compromises speckle-associated gene expression. By integrating tissue culture functional studies with tumor genomic and imaging analysis, we show that HIF-2 gene regulatory programs are impacted by specific manipulation of speckle phenotype and by abrogation of speckle targeting abilities of HIF-2. These findings suggest that, in ccRCC, a key biological function of nuclear speckles is to modulate expression of a specific subset of HIF-2-regulated target genes that, in turn, influence patient outcomes. We also identify STMs in other transcription factors, suggesting that DNA-speckle targeting may be a general mechanism of gene regulation. HIGHLIGHTS- Nuclear speckles shown to reproducibly vary in cancer, predicting patient survival in ccRCC - HIF-2 drives DNA/gene-speckle contacts dependent on identified speckle targeting motifs within HIF-2 - Putative speckle targeting motifs are highly enriched among regulators of gene expression - Partitioning of transcription factor functional programs may be a major biological function of nuclear speckles

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Molecular Cancer Research
42 papers in training set
Top 0.1%
12.3%
2
Scientific Reports
3102 papers in training set
Top 7%
10.1%
3
PLOS ONE
4510 papers in training set
Top 19%
10.1%
4
Cancers
200 papers in training set
Top 2%
3.1%
5
eLife
5422 papers in training set
Top 30%
2.9%
6
Molecular Biology of the Cell
272 papers in training set
Top 1%
2.1%
7
Disease Models & Mechanisms
119 papers in training set
Top 0.8%
2.1%
8
NAR Cancer
36 papers in training set
Top 0.1%
2.1%
9
Cells
232 papers in training set
Top 2%
2.1%
10
Frontiers in Molecular Biosciences
100 papers in training set
Top 1%
2.1%
11
Genome Medicine
154 papers in training set
Top 4%
1.9%
50% of probability mass above
12
iScience
1063 papers in training set
Top 12%
1.9%
13
Frontiers in Genetics
197 papers in training set
Top 4%
1.8%
14
Cell Reports
1338 papers in training set
Top 23%
1.8%
15
Oncogene
76 papers in training set
Top 1%
1.7%
16
International Journal of Molecular Sciences
453 papers in training set
Top 8%
1.7%
17
Molecular and Cellular Biology
40 papers in training set
Top 0.2%
1.7%
18
Nucleic Acids Research
1128 papers in training set
Top 11%
1.7%
19
Cancer Research
116 papers in training set
Top 2%
1.5%
20
Cancer Letters
32 papers in training set
Top 0.4%
1.3%
21
Neoplasia
22 papers in training set
Top 0.4%
1.2%
22
Computational and Structural Biotechnology Journal
216 papers in training set
Top 6%
1.2%
23
Oncotarget
15 papers in training set
Top 0.2%
1.2%
24
BMC Cancer
52 papers in training set
Top 2%
0.9%
25
PLOS Computational Biology
1633 papers in training set
Top 21%
0.9%
26
Translational Oncology
18 papers in training set
Top 0.3%
0.9%
27
Frontiers in Oncology
95 papers in training set
Top 3%
0.9%
28
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 8%
0.8%
29
Communications Biology
886 papers in training set
Top 21%
0.8%
30
Cell Communication and Signaling
35 papers in training set
Top 1.0%
0.8%